IL9 and breast neoplasm: These results represent IL-9 as an inhibitor of adaptive responses, so blocking IL-9 could be proposed as a therapy that limits tumor growth; however, the exact role of these cells in immune responses to breast tumors and their trafficking pattern need further in vivo and in vitro studies (Figure 2).